Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 41

Trial Status

Completed2
Terminated1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02108600Phase 2Completed
Tocilizumab for Renal Graft Inflammation
Late Complication From Kidney Transplant
PrincipalinvestigatorStart date: 2014-06-01
NCT00346151Phase 2Terminated
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
Renal Transplant
Principalinvestigator
NCT02088931Phase 1Completed
Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation
Late Complication From Kidney Transplant
Principalinvestigator
NCT02939365Phase 4Withdrawn
Precision Medicine Offers Belatacept Monotherapy
Transplantation
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, San Francisco

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02108600Phase 2PrincipalInvestigator

Tocilizumab for Renal Graft Inflammation

Late Complication From Kidney Transplant
Completed
NCT00346151Phase 2PrincipalInvestigator

Belatacept to Prevent Organ Rejection in Kidney Transplant Patients

Renal Transplant
Terminated
NCT02088931Phase 1PrincipalInvestigator

Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation

Late Complication From Kidney Transplant
Completed
NCT02939365Phase 4PrincipalInvestigator

Precision Medicine Offers Belatacept Monotherapy

Transplantation
Withdrawn

All 4 trials loaded